Document:

Exhibit 10.1

 

CLAIM INVESTMENT
AGREEMENT

 

This Claim Investment Agreement (“Agreement)
is made and entered into on March 4, 2016, by and between Hillair Capital Management LLC, a Delaware limited liability company
with offices at 345 Lorton Avenue, Suite 303, Burlingame, CA 94010 (“HCM”) and Pro fit Optix, Inc. a Wyoming corporation
with offices at 7501 Esters Blvd., Suite 100, Irving, TX 75063 (“PFO,” or the “Corporation”). HCM and PFO
shall be individually referred to as a “Party” and collectively as the “Parties.”

 

WHEREAS, PFO is presently a party in a lawsuit
captioned VSP Labs, Inc. v Pro Fit Optix, Inc. pending in Sacramento Superior Court, Sacramento County, California, Action
No. 34-2013-00153788 (the “Lawsuit”).

 

WHEREAS, PFO may file new claims and/or
causes of actions, including claims and actions in federal and state courts, and arbitration proceedings, against VSP Labs, Inc.
(“VSP”) and/or any other party that may be added or substituted. VSP and all present and future parties to the Lawsuit
other than PFO shall be individually referred to as the “Defendant” and jointly referred to as the “Defendants.”
Each present and/or future claim or cause of action shall be individually referred to as the “Claim” and collectively
referred to as the “Claims.”

 

WHEREAS, the Defendants have refused to
advance funds or declined payment at this time of an amount which PFO considers fair or adequate, and that it will take an undetermined
amount of time to seek justice through the courts or negotiations to otherwise persuade the Defendants to pay PFO the amount to
which it believes it is entitled.

 

WHEREAS, PFO does not have sufficient funds
to continue litigation against the Defendants and has approached HCM to provide non-recourse funding to PFO for purposes of furthering
its Claim.

 

WHEREAS, PFO seeks to raise capital to fund
the litigation against the Defendants by selling interests in any Recovery (as defined in Schedule “A”, attached hereto
and made a part hereof for all purposes) that it may receive from the Claim (hereinafter referred to as the “Proceeds”)
in return for a funding facility sufficient to cover all the expenses associated with the Claim so as to permit PFO continued access
to the civil justice system;

 

WHEREAS, HCM has previously caused Hillair
Capital Investment LP (“HCI”) to provide $75,000 to pay certain of PFO’s legal fees and expenses and wishes to
cause HCI to make additional Investments (as defined in Section 1 below) in any Recovery received by PFO from the Claim, in accordance
with the terms of this Agreement.

 

    	 	1	 

     

    

 

NOW, THEREFORE, it is agreed as follows:

 

1.             Funding Investment Amount

 

PFO may from time to time submit to HCM directions
to pay, or fund in advance, the legal fees and expenses of Walsh Law Firm (together with any successor Attorney of Record, the
“Attorney of Record”) arising in connection with the Lawsuit. Such direction shall include a certification of an officer
of PFO that such amounts are to be used by the Attorney of Record solely in connection with the Lawsuit. Subject to Sections 2,
and 3 and 15, HCM will cause HCI to pay such legal fees and expenses on PFO’s behalf by wire transfer to the Attorney of
Record promptly upon direction from PFO. Each payment made under this Section 1 shall be an “Investment” and the sum
of the amount of all Investments made, plus $75,000, shall be referred to collectively as the “Investment Amount.”

 

2.             Termination as Sole Remedy of PFO.

 

If for any reason HCM does not cause HCI to
pay any legal fees or expenses as provided in Section 1, the sole and exclusive remedy of PFO will be to terminate this Agreement
as provided in this Section 2. If PFO desires to terminate this Agreement, it shall give 10 days’ prior notice to HCM, specifying
the amount to be paid and stating PFO’s intention to terminate this Agreement if such amount is not paid. If the amount is
not paid within such 10 day period, PFO may then give a second notice, whereupon this Agreement shall be terminated and HCI shall
have no right to payment under Section 5.

 

3.             Conditions Precedent to Investment. Each of the following is a condition precedent to HCM causing HCI to make
any payment under Section 1.

 

		(a)	HCM shall have received, in form and substance satisfactory to HCM, all releases, terminations and such other documents as
HCM may request to evidence and effectuate the termination by the existing lienholders of any interest in and to any assets and
properties with respect to the Claim or the Recovery;

 

    	 	2	 

     

    

 

		(b)	no material adverse change shall have occurred in the prospects of PFO and no change or event shall have occurred which would
impair the ability of PFO to perform its obligations hereunder or under any other agreements to which it is a party or of HCM or
HCI to enforce the rights with respect to the Claim or the Recovery;

 

		(c)	HCM shall have completed due diligence of the records and such other information with respect to the Claim, PFO, or any of
its affiliates, as HCM may require, the results of which shall be satisfactory to HCM;

 

		(d)	HCM shall have received, in form and substance satisfactory to HCM, all consents, waivers, acknowledgments and other agreements
from third persons or parties, which HCM may deem necessary or desirable in order to permit, protect and perfect HCI’s its
security interests in and liens upon the Claim and/or the Recovery or to effectuate the provisions or purposes of this Agreement
and any other agreements between the parties;

 

		(e)	HCM shall have received evidence, in form and substance satisfactory to HCM, that HCI has a valid perfected first priority
security interest in all of the Claim and the Recovery;

 

		(f)	HCM shall have received and reviewed lien, judgment, and background search results for PFO, and any other individual or entity
that HCM deems is appropriate, which search results shall be in form and substance satisfactory to HCM;

 

		(g)	HCM shall have received, in form and substance satisfactory to HCM, such opinions of counsel with respect to the Claim and
such other matters as HCM may request;

 

		(h)	any and all instruments and documents hereunder shall have been duly executed and delivered to HCM, in form and substance satisfactory
to HCM;

 

    	 	3	 

     

    

 

		(i)	all representations and warranties contained herein and in the other agreements between the parties shall be true and correct
in all material respects with the same effect as though such representations and warranties had been made on and as of the date
of the making of the Investment and after giving effect thereto, except to the extent that such representations and warranties
expressly relate solely to an earlier date (in which case such representations and warranties shall have been true and accurate
on and as of such earlier date);

 

		(j)	no law, regulation, order, judgment or decree of any governmental authority shall exist, and no action, suit, investigation,
litigation or proceeding shall be pending or threatened in any court or before any arbitrator or governmental authority, which
purports to enjoin, prohibit, restrain or otherwise affect the making of the Investment;

 

		(k)	no law, regulation, order, judgment or decree of any governmental authority shall exist, and no action, suit, investigation,
litigation or proceeding shall be pending or threatened in any court or before any arbitrator or governmental authority, which
(i) purports to enjoin, prohibit, restrain or otherwise affect (A) the making of the Investment, or (B) the consummation of the
transactions contemplated pursuant to the terms hereof or (ii) has or could reasonably be expected to have a material adverse effect
on the prospects of PFO or would impair the ability of PFO to perform its obligations hereunder or of HCM or HCI to enforce any
rights or realize upon the Claim and the Recovery;

 

		(l)	no Default or Event of Default shall exist or have occurred and be continuing on and as of the date of the making of the Investment
and after giving effect thereto.

 

4.            Non-Recourse Investment. Subject to Section 40, PFO hereby acknowledges and confirms that it understands that
HCM shall cause HCI to make payments on behalf of PFO pursuant to Section 1 on a non-recourse basis. Subject to Section 40, in
the event a final disposition or settlement of the Claim fails to result in a Recovery, as defined herein, then PFO shall have
no obligation to make any payment to HCI for any portion of HCI Return, as defined in Section 5 below.

 

    	 	4	 

     

    

 

5.            Payments by PFO to HCM. In consideration for HCM agreeing to cause HCI to invest funds as set forth in Section
1 above, if and only if, a final disposition or settlement of the Claim results in a Recovery to PFO, PFO shall pay (or cause to
be paid) to HCI the return (the “HCI Return”) as follows: First, 100% of any Recovery, until HCI has received an amount
equal to the Investment Amount; and second, 50% of the amount of any Recovery, in excess of the Investment Amount.

 

6.            Order of Payments Schedule. All payments made by PFO (or by the Attorney of Record) to HCI shall be made from
the total amount of Recovery actually received by PFO and its Attorney of Record. The following order of payments shall apply:

 

		(a)	to HCI; and then

 

		(b)	to PFO and other third-party lien holders, including any statutory, government and/or perfected liens.

 

7.            Time of Payment. If and when a final disposition or settlement of the Claim(s) results in a Recovery, PFO
shall pay (or cause to be paid) to HCI all (or the proportionate share, as the case may be) of its HCI Return in accordance with
the Order of Payments Schedule in Section 6 above within three (3) business days following the receipt of the cleared proceeds
by PFO’s Attorney of Record. HCI shall be entitled to one hundred percent (100%) of the proceeds of each Claim until the
aggregate amount received by HCI equals the amount of HCI Return.  If such Recovery is received by PFO in installments over
time, then PFO (if necessary, because the amounts of such installments are insufficient to pay all HCI Return) shall pay HCI its
respective HCI Return in installments (over the same period of time) in accordance with the Order of Payments Schedule in Section
6 above, until such time as HCI Return (or its proportionate share thereof) shall have been paid in full.

 

8.            Payments in Trust. If PFO or any representative person or entity receives all or any part of the proceeds
from the Recovery, then PFO or representative shall hold those proceeds in trust and shall cause those proceeds to be paid or delivered
to HCI within three (3) business days.

 

    	 	5	 

     

    

 

9.            Interest in the Event of Non-Payment. In the event payment is not made to HCI in accordance with Section 7
above for any reason whatsoever, PFO shall pay to HCI interest of twenty-four percent (24%) per annum on any unpaid balances until
paid in full.

 

10.          Security Interest. In order to secure the payment of HCI Return, PFO hereby grants to HCI a security interest
in the amount of HCI Return against PFO’s portion of any Recovery. PFO agrees to deliver to HCM each document, instrument
of assignment, financing statement, or other writing, which HCM shall reasonably deem necessary or desirable to perfect the security
interest granted herein, or otherwise to accomplish the specific purpose of this Agreement. Furthermore, PFO agrees to execute
and deliver to HCM an “Assignment” of HCI’ s portion of any Recovery in the form set forth on Schedule “B”
attached hereto and made part hereof, within three (3) calendar days hereof. PFO further agrees to execute, acknowledge and deliver
such other documents, and take such other actions as are necessary, appropriate and reasonably requested by HCM to document that
HCI has a security interest in its portion of the Recovery.

 

11.          Subsequent Investments. PFO and HCM acknowledge and agree that, from time to time, PFO may desire to sell
and HCM may desire to cause HCI to purchase, additional interests in this Claim(s) and any other claims which may be in addition
to, or in substitution of, the interests from the Claim(s) purchased hereunder on the date. Any transaction contemplated by this
Section 11 shall be evidenced by a separate written instrument.

 

12.          No Reduction of HCM’s Entitlement. PFO hereby acknowledges and confirms that neither HCM nor HCI is
under no obligation to PFO to reduce the amount of HCI Return in the event PFO obtains a recovery from the Claim(s). PFO hereby
agrees and covenants with HCM and HCI that PFO has been advised of and agreed to the potential amount of the fees and that neither
they nor anyone else on its behalf shall contact HCM of HCI to request a reduction of HCI Return. Any violation of this Section
12 shall increase PFO’s obligation to HCI by fifty percent (50%). Any request by PFO for such a reduction shall constitute
an Event of Default.

 

13.          Multiple Claims. If any Claim results in a Recovery, HCI shall be entitled to receive its entire HCI Return
from the proceeds of any and all Claims that result in a Recovery paid to PFO by or on behalf of one or more of the Defendants.

 

    	 	6	 

     

    

 

14.          Right of First Refusal. PFO hereby grants HCM the exclusive right of “first refusal” for any additional
funding that PFO may desire with respect to the Claim(s). Failure by PFO to present additional requests for funding to HCM pursuant
hereto shall constitute an Event of Default.

 

15.          Cumulative Limitation on Funding. PFO hereby agrees
to limit all advances, including advances previously taken against the Claim, to a total of Two Hundred Fifty Thousand Dollars
($250,000). In the event PFO receives any additional funding with respect to the Claim(s) from any other sources than HCI in violation
hereof without HCM’s express written consent, HCI’s entitlement pursuant to this Agreement shall increase by an additional
fifty percent (50%). Such a violation by PFO shall also constitute an Event of Default.

 

16.          No Transfer of Underlying Claim(s). The Parties to this Agreement intend to sell and to purchase the right
to receive a portion of the proceeds recovered with respect to the Claim(s). This Agreement does not transfer or convey any right
of action, cause of action or claim for relief which PFO may have against any of the defendants in the Claim(s) or any other person
or entity arising out of the facts, transactions, occurrences or events which are alleged in, or are the subject of, the complaint,
as amended, on file in the Claim(s). Neither HCM nor HCI shall have any right to control, interfere with, or influence the prosecution
of the case on behalf of PFO with respect to the Claim(s) or any settlement negotiations that may occur.

 

17.          No Agents of HCM or HCI. PFO hereby acknowledges and confirms that in the event any broker or intermediary
referred it to HCM for funding, such broker or intermediary is an agent of PFO and not an agent of HCM or HCI.

 

18.          Irrevocable Instructions to Attorney of Record. PFO hereby irrevocably requests, instructs, and directs its
Attorney of Record with respect to the Claim(s) to:

 

		(a)	sign this Agreement in the Attorney Acknowledgment and Undertaking section, which is attached to this Agreement as Schedule
“E” and made a part hereof, to acknowledge notice of this Agreement and the rights created thereby, to disclose to
HCM all assignments, conveyances and transfers of, and liens upon the proceeds and to distribute the proceeds to HCI in compliance
with the provisions herein;

 

    	 	7	 

     

    

 

		(b)	keep HCM updated regarding any changes affecting this case and to provide detailed updates regarding the case status at HCM's
request;

 

		(c)	in the event of any dispute regarding the amount due to HCI, deposit into the client trust account established and controlled
by the Attorney of Record the full amount of the Recovery paid to PFO by or on behalf of one or more of the Defendants. Said amount
shall remain in the client trust account until resolution of such dispute;

 

		(d)	in the event PFO substitutes another lawyer or law firm as its Attorney of Record with respect to the Claim(s), give HCM immediate
written notice thereof by certified mail, return receipt requested, and state the name, address, email and telephone number of
PFO’s new Attorney of Record;

 

		(e)	notify HCM in writing if and when PFO enters into an agreement with any Defendant to settle the Claim(s) or any portion thereof,
and to notify HCM in writing if and when PFO, or its attorney, receives any proceeds from the Claim(s);

 

19.          New Attorneys of Record. If PFO substitutes another lawyer or law firm as its Attorney of Record with respect
to the Claim(s), PFO hereby irrevocably requests and instructs its new attorney(s) to:

 

		(a)	acknowledge this Agreement by signing it in the appropriate space below and to distribute the Recovery in accordance with this
Agreement;

 

		(b)	keep HCM updated regarding any changes affecting this case and to provide detailed updates regarding the case status at HCM’s
request;

 

		(c)	notwithstanding anything to the contrary, strictly comply with all obligations contained in and derived from this Agreement,
including any exhibits, schedules, appendices and acknowledgments.

 

    	 	8	 

     

    

 

20.          Notification of HCM. PFO promises and agrees to promptly notify HCM in writing if and when PFO enters into
an agreement with any Defendant to settle the Claim(s) or any portion thereof, and to notify HCM in writing if and when PFO, or
its attorney, receives any proceeds from the Claim(s).

 

21.          Notification of Defendant. HCM reserves the right to notify the Defendant(s) and/or the Defendant(s)’
attorney(s) and/or the Defendant(s)’ insurance company(s) regarding the existence and amount of PFO’s obligations in
connection with this Agreement and furnish them with a copy of this Agreement.

 

22.          Other Liens. PFO hereby represents and warrants to HCM that it does not have any notice or knowledge of any
liens upon the proceeds with respect to the Claim(s), and it has not assigned, transferred or conveyed any right to any portion
of the proceeds to any person or entity, except as provided in the Attorney Acknowledgement section below.

 

23.          Bankruptcy. In the event PFO commences, or has commenced against it, any case (or other proceeding) pursuant
to any bankruptcy, insolvency or similar law prior to HCI’s receipt of its HCI Return, PFO shall cause HCI Return to be described
as an asset of HCI in any oral or written communications, including, but not limited to, any schedule or other document, made or
filed in connection with any such case or proceeding. In no event shall PFO permit HCI’s interest in any Recovery to be described
as a debt or obligation of PFO to HCI in any such communication.

 

24.          Retention of New or Additional Attorney(s). PFO shall notify HCM in writing within five (5) calendar days
after PFO contracts or retains a new or additional attorney(s) to handle the Claim(s), if such contracts or retainer agreements
are entered into prior to HCI’s receipt of all of its HCI Return. Such notice shall include the name, address, email and
telephone number of said attorneys and, subject to Section 25 hereunder, any percentage interest in the Recovery (if applicable)
offered to compensate said attorneys. PFO’s failure to comply with this Section shall increase PFO’s obligation to
HCI by fifty percent (50%).

 

25.          Payments to New Attorneys. Any compensation offered by PFO or any of its affiliates to any additional or substituted
attorneys on a contingency basis shall be expressly approved by HCM in writing, which approval may be withheld by HCM at HCM’s
sole and absolute discretion.

 

    	 	9	 

     

    

 

26.          Waiver of Conflicts. PFO hereby waives any conflicts of interest that may arise as a result of the Attorney
of Record’s compliance with the rights and obligations created by this Agreement.

 

27.          Confidentiality. Any party that discloses confidential information (the “Confidential Information”)
to any other party shall be referred to as the “Disclosing Party.” Any party that receives Confidential Information
from any Disclosing Party shall be referred to as the “Recipient.” The Parties agree to treat confidentially all information
disclosed pursuant to this Agreement and further agree as follows:

 

27.1.
The Recipient agrees and acknowledges that all Confidential Information provided to it and shall remain at all times the
exclusive property of and owned by the Disclosing Party and the Recipient’s use or a awareness of such Confidential Information
shall create no rights, at law or in equity, in the Recipient in or such information, or any aspect of embodiment thereof. Neither
the execution of this Agreement nor the funding relating to any Confidential Information hereunder, shall be license to distribute
or title to any patent, trademark, service mark, business and trade secret or other propriety right to such Confidential Information,
or to use such Confidential Information for any purpose other than as specified in this Agreement or to constitute a waiver of
any attorney-client privilege or work product protection.

 

27.2.
The Recipient shall not for any reason, during the term of this Agreement and for a period of two (2) years following termination
of this Agreement, disclose use, reveal report, publish, transfer, or make available, directly or indirectly to any person other
than its any Confidential Information provided to it except in connection with the performance of its obligations under this Agreement
or as permitted by the Disclosing Party.

 

27.3.
For the avoidance of doubt, no press release or other announcement concerning the existence of this Agreement, the funding
of the Claim(s) under this Agreement, or the identity of HCM or its affiliates, shall be made by PFO or HCM without the prior written
consent of the other.

 

    	 	10	 

     

    

 

27.4.
The Recipient shall ensure that the Confidential Information it received is not divulged or disclosed to any Person except
its Representatives who have a “need to know” such information. The Recipient shall be solely responsible for its and
its Representatives’ failure to comply with, and shall ensure its Representatives’ compliance with the provision of
this Agreement.

 

27.5.
The Recipient recognizes and agrees that (i) the covenants and agreements contained in this Agreement are reasonable and
necessary to protect and preserve the interests proprieties of the Disclosing Party, (ii) irreparable loss and damage will be suffered
be the Disclosing Party should the Recipient breach any such covenants and agreement, (iii) each such covenants and agreements
separate, distinct and severable from the other and remaining provisions of this Agreement, (iv) if any such covenant is found
by a court of competent jurisdiction to be overly broad in any respect, the Recipient desires and directs that such covenant be
amended by such court to a reasonable breadth, and (v) in addition to other remedies available to it, the Disclosing Party shall
be entitled to both temporary and permanent injunction to prevent a breach of completed breach by the Recipient or any of its Representatives
of any such covenants or agreements.

 

27.6.
The Recipient further agrees not to reproduce or in any manner copy the Confidential Information, in whole or in part, except
for its own internal use for the purpose of this Agreement and then only under circumstances designed to ensure the full and complete
protection of the Confidential Information as contemplated hereby.

 

27.7.
PFO agrees that, within thirty (30) calendar days following the termination of this Agreement, it shall destroy or return
all HCM Confidential Information to HCM, and PFO shall not for any reason retain or use any such HCM Confidential Information or
any copies thereof.

 

27.8.
In the event one of the Parties receives a request, including without limitation a subpoena, civil investigation demand
or similar process, for the production of Confidential Information (a “Request”), that party, before complying with
such Request, will first promptly provide written notification, including a copy of the Request, to the other party. If, upon such
notice, any party elects to contest the requested disclosure (all such contests being at the contesting party’s expenses
and control), no party shall make any disclosure until such time as a final, non-appealable or non-stayed order has been entered
compelling such disclosure. Should the Disclosing Party not contest the required disclosure, the Recipient shall not have any obligation
to do so; the Recipient may, however, contest the required disclosure even if the Disclosing Party elects not to do so. If notice
to the Disclosing Party is prohibited by law, the Recipient will make a good faith effort to contest the disclosure if appropriate
and to obtain agreement or confidential treatment of the Confidential Information prior to Recipient’s disclosure.

 

    	 	11	 

     

    

 

28.           Power of Attorney. PFO hereby irrevocably appoints HCM as its true and lawful attorney-in-face, in its name,
place and stead, with full powers to request and receive all information related to the Claim(s) from any sources, including but
not limited to, medical providers, attorneys, insurance companies, law enforcement, and government organizations. This power of
attorney is irrevocable and shall remain in full force and be binding on PFO and any affiliates until HCI receives its HCI Return
in accordance with the terms of this Agreement.

 

29.           Representations and Warranties of PFO. PFO hereby makes the following representations and warranties to HCM
and HCI:

 

		(a)	PFO is a company duly incorporated, validly existing and in good standing under the laws of the jurisdiction of its incorporation
and has all power and authority required to carry on its business as now conducted;

 

		(b)	The execution, delivery and performance by PFO of this Agreement are within PFO’s corporate powers and have been duly
authorized by all necessary corporate action. This Agreement constitutes a legal, valid and binding agreement of PFO enforceable
against it in accordance with its terms (i) except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other similar laws now or hereafter in effect relating to or affecting creditors' rights generally, including the
effect of statutory and other laws regarding fraudulent conveyances and preferential transfers, and (ii) subject to the limitations
imposed by general equitable principles regardless of whether such enforceability is considered in a proceeding at law or in equity;

 

    	 	12	 

     

    

 

		(c)	The execution, delivery and performance of this Agreement do not and shall not (i) contravene or conflict with the charter,
bylaws or other organizational documents of PFO, or (ii) constitute a default under, or give rise to any right of termination,
cancellation or acceleration of, or to a loss of any benefit that may affect HCM’s or HCI’s rights under this Agreement;

 

		(d)	all information furnished by or on behalf of PFO in writing to HCM in connection with this Agreement or any transaction contemplated
hereby or thereby is true and correct in all material respects on the date as of which such information is dated or certified and
does not omit any material fact necessary in order to make such information not misleading. No event or circumstance has occurred
which has had or could reasonably be expected to have a material adverse effect on the business, assets or prospects of PFO, which
has not been fully and accurately disclosed to HCM in writing;

 

		(e)	PFO has received independent legal advice on the terms and effect of this Agreement;

 

		(f)	PFO is the sole and beneficial owner of, and have good title to, the Claim(s) free and clear of any (a) mortgage, pledge, lien,
charge, hypothecation, right of set-off or counterclaim, security interest or other encumbrance, security agreement or trust securing
any obligation of any person or arrangement of any kind; (b) purchase or option agreement or arrangement; (c) subordination agreement
or arrangement; (d) agreements to create or effect any of the foregoing or which have a similar or analogous nature or effect,
in each case other than disclosed to HCM in writing;

 

    	 	13	 

     

    

 

		(g)	PFO has not made or entered into any prior assignment, trust arrangement, security, sale, transfer, or sub-participation or
equivalent interest in the Claim(s), other than as previously disclosed to HCM in writing;

 

		(h)	PFO has not taken any steps or executed any documents which would materially or adversely affect the Claim(s) or the recoverability
of the Recovery other than as previously disclosed to HCM in writing;

 

		(i)	PFO has not engaged in any acts or conduct or made any material omissions, agreements or arrangements, that would result in
HCI receiving proportionally less payments or less favorable treatment with respect to the Claim(s) or the Recovery than any other
PFO or litigant (including PFO) pursuing or enforcing such Claim(s) or Recovery other than as previously disclosed to HCM in writing;

 

		(j)	PFO has not set-off or agreed to set-off any amounts against the Claim(s) or the Recovery and no rights of set-off, or similar
rights against PFO exist which will permit any set-off or counterclaim against the Claim(s) and/or Recovery other than as previously
disclosed to HCM in writing;

 

		(k)	such PFO has not received any written notice and are not otherwise to the best of its knowledge aware that the Claim(s) or
Recovery or any portion thereof are subject to an impairment or is otherwise invalid or void, other than as previously disclosed
to HCM in writing;

 

		(l)	PFO has no bankruptcy or insolvency proceedings outstanding against it;

 

		(m)	to the best knowledge of PFO, PFO has disclosed to HCM all documentation and other information in its possession or control
relevant to PFO, and there is no information in the knowledge, possession or control of PFO that is or is reasonably likely to
be material to HCM’s assessment of the Claim(s) that has not been disclosed to HCM, and PFO believes that the Claim(s) is/are
meritorious and likely to prevail;

 

    	 	14	 

     

    

 

		(n)	there are no agreements (whether in writing or oral) between PFO and another person(s) or entity or entities to grant a contingent
interest in, or to grant a right of payment determined by reference to, the Recovery or the proceeds with respect to the Claim(s)
thereof in favor of any party except HCI;

 

		(o)	PFO has not failed to disclose to HCM any fact or facts of which it is aware that would, if HCM had been so advised, be reasonably
expected, individually or in the aggregate, to have led HCM not to enter into this Agreement;

 

		(p)	no fraud has been perpetrated by PFO or any affiliate in connection with this Agreement or the Claim(s).

 

30.           Survival of Warranties; Cumulative. All representations and warranties contained in this Agreement or any
of the other agreements between the Parties shall survive the execution and delivery of this Agreement. The representations and
warranties set forth herein shall be cumulative and in addition to any other representations or warranties which shall now or hereafter
give, or cause to be given, to HCM and/or HCI.

 

31.           Common Interest. The Parties acknowledge and mutually represent to each other that it is their common purpose
in executing this Agreement to enable PFO to pursue its Claim(s). The Parties further agree that this common purpose and all steps
and actions required to achieve this common purpose, including but not limited to any and all steps and actions require in accordance
with PFO’s obligation to cooperate with HCM and HCI as set forth herein, are of the essence of this Agreement.

 

32.           Authority to Settle Claim. The Parties acknowledge that their common interest is served by settling the Claim(s)
for a commercially reasonable amount in the context of the damage done by the Defendant(s). In that context, notwithstanding anything
to the contrary contained in this Agreement, PFO may at any time without the consent of HCM or HCI, either settle or refuse to
settle the Claim(s) for any amount.

 

    	 	15	 

     

    

 

33.           No Encumbrances. PFO shall not create, and shall not permit anyone else to create or permit to exist any security
interest, mortgage, pledge, lien, charge or other encumbrance of any nature in the Claim(s), the Recovery and/or HCI Return. PFO
shall not, and will not allow any other party (except HCI or HCI’s assignee, if applicable) to take funds away from the Claim(s)
and/or the Recovery and/or HCI Return. PFO will not do anything else to affect the Claim(s) and/or the Recovery and/or HCI Return.
PFO will not do anything to allow anyone else to do anything that could in any way hurt or lessen HCM’s or HCI’s rights
under this Agreement. PFO shall, as reasonably requested by the Attorney of Record, lend its name to all required actions and steps
in relation to the Claim(s), and shall execute all papers and documents and shall render assistance to HCM so as to secure to HCM
and HCI the benefits, rights and causes of action contained in this Agreement. Any violation of this Section 33 shall constitute
an Event of Default.

 

34.           PFO’s Cooperation. PFO further
irrevocably instructs the Attorney of Record to keep HCM fully and continually informed of all material developments (including
the matters set forth below) and to provide HCM with copies of all material documents. PFO and HCM agree that the Attorney of Record
may not disclose information or documents that the Attorney of Record reasonably believes could jeopardize any privilege (including,
but not limited to, the attorney-client privilege) of PFO. Any violation of this Section 34 shall constitute an Event of Default.
In furtherance of the foregoing, PFO shall, as requested by HCM:

 

		(a)	cooperate with the Attorney of Record and HCM in all material matters pertaining to the Claim(s) and devote sufficient time
and attention as is reasonably necessary to conclude the Claim(s);

 

		(b)	provide to the Attorney of Record all material documentation necessary to further the Claim(s);

 

		(c)	submit to examination by the Attorney of Record for the preparation of written statements, subscribe to the same under oath
if required, consult with the Attorney of Record and its designees as they reasonably require for purposes of pursuing the Claim(s)
or enforcing or settling the Claim(s) and appear at any proceeding or hearings (including hearings located abroad) reasonably required
in connection with such statements or the Claim(s) generally; and

 

    	 	16	 

     

    

 

		(d)	using PFO’s reasonable efforts and subject to any relevant legal rules, cause all persons related to the Claim(s), including
PFO’s lawyers, to submit to examination by the Attorney of Record for the preparation of statements, to subscribe to the
same under oath if required, to consult with the Attorney of Record as they reasonably require for purposes of pursuing the Claim(s)
or enforcing or settling the Claim(s) and to appear at any hearings (including hearings located abroad) reasonably required in
connection with such statements or the Claim(s) generally.

 

34.           No Further Action by PFO. PFO agrees and undertakes not to initiate any action, suit or arbitration proceeding
separate from the Claim(s) against any Defendant or take any other step that is reasonably likely to have a materially adverse
effect on the Claim(s).

 

35.           Non-Circumvention. PFO agrees that they shall not directly or indirectly interfere with, circumvent, or attempt
to circumvent, avoid, by-pass, or obviate the interest of HCI contemplated hereby in any way whatsoever. Any violation of this
Section 36 shall increase PFO’s obligation to HCI by fifty percent (50%). Any attempt by PFO to circumvent HCM or HCI shall
constitute an Event of Default.

 

36.           No Interpleader. PFO agrees not to instruct, cause, or otherwise permit the Attorney of Record, or any other
attorney, agent, representative, entity, or person to interplead or otherwise deposit with any state or federal court or tribunal
any funds or proceeds from the Claim unless such interpleader is expressly initiated or requested in writing by HCM. Any violation
of this Section 37 shall increase PFO’s obligation to HCI by fifty percent (50%). Any attempt to interplead the funds shall
constitute an Event of Default.

 

37.           Obligation to Cooperate is of the Essence. The Parties acknowledge and agree that PFO’s obligation to
cooperate as set forth in Section 34 is of the essence of this Agreement and is a condition thereof and a continuing obligation
and that any material breach thereof that has a material adverse effect on the value of the Claim(s) shall constitute an Event
of Default.

 

    	 	17	 

     

    

 

38.           Events of Default. The occurrence or existence of any one or more of the following events are referred to
herein individually as an “Event of Default,” and collectively as “Events of Default:”

 

		(a)	PFO fails to pay when due any of HCI Return;

 

		(b)	any representation, warranty or statement of fact made by PFO to HCM or HCI in this Agreement, any other agreements between
the Parties, schedules, confirmatory assignments or otherwise shall when made or deemed made be false or misleading in any material
respect;

 

		(c)	PFO revokes, terminates, breaches or otherwise fails to perform any of the terms, covenants, conditions or provisions of any
guarantee, endorsement in favor of HCM or HCI;

 

		(d)	a case or proceeding under the bankruptcy laws of the United States of America now or hereafter in effect or under any insolvency,
reorganization, receivership, readjustment of debt, dissolution or liquidation law or statute of any jurisdiction now or hereafter
in effect (whether at law or in equity) is filed by PFO, and such petition or application is not dismissed within thirty (30) calendar
days after the date of its filing;

 

		(e)	any material provision hereof shall for any reason cease to be valid, binding and enforceable with respect to any Party hereto
in accordance with its terms, or any such Party shall challenge the enforceability hereof or thereof, or shall assert in writing,
or take any action or fail to take any action based on the assertion that any provision hereof has ceased to be or is otherwise
not valid, binding or enforceable in accordance with its terms, or any security interest provided for herein shall cease to be
a valid and perfected first priority security interest in the Claim(s), the Recovery, and HCI Return purported to be subject thereto
(except as otherwise permitted herein or therein);

 

    	 	18	 

     

    

 

		(f)	the indictment by any governmental authority, or as HCM may reasonably and in good faith determine, the threatened indictment
by any governmental authority of any director or officer of PFO;

 

		(g)	there shall be an event of default under any of the other agreements between the Parties;

 

		(h)	HCI shall fail to have a first priority perfected security interest in the Claim(s) and the Recovery as a result of action
taken by PFO or any of its respective affiliates;

 

		(i)	PFO requests HCI to reduce the amounts to which it is entitled pursuant to this Agreement in violation of Section 12;

 

		(j)	PFO fails to offer HCM the right of first refusal in violation of Section 14;

 

		(k)	PFO violates the cumulative funding restrictions contained in Section 15;

 

		(l)	PFO violates the restrictions on encumbrances contained in Section 33;

 

		(m)	PFO fails to cooperate as set forth in Section 34;

 

		(n)	PFO attempts to circumvent HCM or HCI in violation of Section 36;

 

		(o)	PFO or the Attorney of Record interpleads any of the Recovery in violation of Section 37;

 

		(p)	PFO accepts or attempts to accept or negotiate offer of settlement or receive recovery from any of the Defendants or the Defendants’
attorneys without prior disclosure to its Attorney of Record;

 

		(q)	PFO acts in bad faith.

 

    	 	19	 

     

    

 

39.           Rights and Remedies. In addition to any rights and remedies HCM or HCI is entitled to, whether in law or equity,
HCM and HCI shall also have the rights and remedies set forth below.

 

		(a)	At any time an Event of Default exists or has occurred and is continuing, HCM and HCI shall have all rights and remedies provided
in this Agreement and other applicable law, all of which rights and remedies may be exercised without notice to or consent by PFO,
except as such notice or consent is expressly provided for hereunder or required by applicable law. All rights, remedies and powers
granted to HCM or HCI hereunder, or other applicable law, are cumulative, not exclusive and enforceable, in HCM’s discretion,
alternatively, successively, or concurrently on any one or more occasions, and shall include, without limitation, the right to
apply to a court of equity for an injunction to restrain a breach or threatened breach by PFO of this Agreement or any of the other
agreements between the Parties. HCI may, at any time or times, proceed directly against PFO to collect HCI Return without prior
recourse to the Claim(s).

 

		(b)	The non-recourse limitation of Section 4 shall not apply and PFO shall become liable to HCI for any and all obligations contained
in this Agreement at any time an Event of Default exists or has occurred and is continuing.

 

		(c)	Without limiting the foregoing, at any time an Event of Default exists or has occurred and is continuing, HCM may, in its discretion
and without limitation, (i) accelerate the payment of all obligation and demand immediate payment thereof to HCI provided, that,
upon the occurrence of any Event of Default described in Section 39 above, all obligations, including HCI Return, shall automatically
become immediately due and payable from PFO), (ii) cease and revoke its Capital Commitment and funding obligations pursuant to
Section 1 of this Agreement, and/or (iii) terminate this Agreement, provided that all of HCM’s and HCI’s rights and
remedies in respect of any Event of Default shall survive any such termination.

 

		(d)	HCM, in its sole and absolute discretion, reserves the right to cease and revoke the funding obligations pursuant to Section
1 of this Agreement in the event of any unfavorable procedural or substantive outcome occurred in furtherance of the Claim(s).
This includes but is not limited to any motions, petitions, verdicts, judgments, orders or appeals granted or entered in favor
of the Defendants, whether fully or partly, or any other events unfavorable to PFO.

 

    	 	20	 

     

    

 

		40.	Governing Law; Choice of Forum; Service of Process; Jury
Trial Waiver.

 

		(a)	The validity, interpretation and enforcement of this Agreement and any dispute arising out of the relationship between the
Parties hereto, whether in contract, tort, equity or otherwise, shall be governed by the internal laws of the State of California
(without giving effect to principles of conflicts of law).

 

		(b)	Subject to the Arbitration Provision contained in Section 42 below, PFO and HCM irrevocably consent and submit to the jurisdiction
of the state courts of California, Sacramento County and waive any objection based on venue or forum non conveniens
with respect to any action instituted therein arising under this Agreement or in any way connected with or related or incidental
to the dealings of the Parties hereto in respect of this Agreement or the transactions related hereto or thereto, in each case
whether now existing or hereafter arising, and whether in contract, tort, equity or otherwise, and agree that any dispute with
respect to any such matters shall be heard only in the courts described above (except that HCM shall have the right to bring any
action or proceeding against PFO or its property in the courts of any other jurisdiction which HCM deems necessary or appropriate
in order to realize on the collateral or to otherwise enforce its of HCI’s rights against PFO or its property).

 

		(c)	PFO hereby waives personal service of any and all process upon it and consents that all such service of process may be made
by certified mail (return receipt requested) directed to its address set forth herein and service so made shall be deemed to be
completed five (5) calendar days after the same shall have been so deposited in the U.S. mails, or, at HCM’s option, by service
upon PFO, as applicable, in any other manner provided under the rules of any such courts. Within thirty (30) calendar days after
such service, PFO shall appear in answer to such process, failing which PFO shall be deemed in default and judgment may be entered
by HCM against PFO for the amount of the claim and other relief requested.

 

    	 	21	 

     

    

 

		(d)	PFO AND HCM EACH HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (i) ARISING UNDER
THIS AGREEMENT OR ANY OF THE OTHER FINANCING AGREEMENTS OR (ii) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS
OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE OTHER FINANCING AGREEMENTS OR THE TRANSACTIONS RELATED HERETO
OR THERETO IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE. PFO AND
HCM EACH HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT
A JURY AND THAT PFO OR HCM MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE
CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

 

		(e)	HCM shall have no liability to PFO or (whether in tort, contract, equity or otherwise) for losses suffered by PFO in connection
with, arising out of, or in any way related to the transactions or relationships contemplated by this Agreement, or any act, omission
or event occurring in connection herewith, unless it is determined by a final and non-appealable judgment or court order binding
on HCM that the losses were the result of acts or omissions constituting gross negligence or willful misconduct of HCM. In any
such litigation, HCM shall be entitled to the benefit of the rebuttable presumption that it acted in good faith and with the exercise
of ordinary care in the performance by it of the terms of this Agreement. Except as prohibited by law, PFO waives any right which
it may have to claim or recover in any litigation with HCM any special, exemplary, punitive or consequential damages or any damages
other than, or in addition to, actual damages. HCI shall have no liability hereunder or in connection herewith. PFO: (i) certifies
that neither HCM nor HCI, nor any representative, agent or attorney acting for or on behalf of either of them has represented,
expressly or otherwise, that HCM or HCI would not, in the event of litigation, seek to enforce any of the waivers provided for
in this Agreement and (ii) acknowledge that in entering into this Agreement HCM is relying upon, among other things, the waivers
and certifications set forth herein.

 

    	 	22	 

     

    

 

41.           Arbitration. Any dispute, claim or controversy arising out of or relating in any way to this Agreement or
the breach, termination, enforcement, interpretation or validity thereof, including any determination regarding the scope or applicability
of this agreement to arbitrate, shall be determined by mandatory, final and binding arbitration before a single arbitrator. The
place of arbitration shall be in San Francisco, California. The arbitrator shall be a practicing attorney licensed to practice
law in the state of California. The arbitration shall be administered by the American Arbitration Association (“AAA”)
pursuant to AAA rules and procedures. All arbitration fees and costs, including any upfront costs and application fees, shall be
borne by both parties in equal shares. Judgment on the award may be entered in any court having jurisdiction. This clause shall
not preclude the Parties from seeking provisional remedies in aid of arbitration from a court of appropriate jurisdiction. In any
arbitration arising out of or related to this Agreement, the arbitrator(s) is/are empowered to award punitive or exemplary damages.
In any arbitration arising out of or related to this Agreement, there shall be no interrogatories or requests to admit. The Parties
acknowledge that this Agreement evidences a transaction involving interstate commerce and further agree that any arbitration(s) arising
from or in relationship to this Agreement is/are to be administered as a commercial matter(s) under the Commercial Rules.

 

42.           Waiver of Notices. PFO hereby expressly waives demand, presentment, protest and notice of protest and notice
of dishonor with respect to any and all instruments and chattel paper, included in or evidencing any of the Claim, the Recovery,
HCI Return, and any and all other demands and notices of any kind or nature whatsoever with respect to the Claim, the Recovery,
HCI Return, and this Agreement, except such as are expressly provided for herein. No notice to or demand on PFO, which HCM may
elect to give shall entitle PFO to any other or further notice or demand in the same, similar or other circumstances.

 

    	 	23	 

     

    

 

43.           Consultation with Attorney. PFO has had an opportunity to review this Agreement and any other agreements between
the Parties with its attorneys, accountants and/or advisors besides the Attorney of Record and has a complete understanding of
this Agreement and any other agreements between the Parties. PFO understands and agrees that such attorneys, accountants and/or
advisors (including any insurance producer) who is advising, or assisting in connection with the transactions contemplated by this
Agreement and any other agreements between the Parties is not acting as an agent of HCM or HCI. Neither PFO has relied upon any
advice from HCM, HCI or any affiliate of either of them, regarding its involvement in this transaction, and has not received and
is not relying on any oral or written representations from any person that are inconsistent with or contrary to the information
contained in this Agreement and any other agreements between the Parties. PFO is signing this Agreement and any other agreements
among the Parties freely and voluntarily and is of sound mind and not subject to any constraint or undue influence, and has never
been the subject to any mental health or mental competency proceeding or other proceeding or hearing with respect to which either
PFO’s competency or capacity to contract is or was an issue.

 

44.           Amendments and Waivers. Neither this Agreement nor any provision hereof shall be amended, modified, waived
or discharged orally or by course of conduct, but only by a written agreement signed by an authorized officer of HCM, and as to
amendments, as also signed by an authorized officer of PFO. Neither HCM nor HCI shall, by any act, delay, omission or otherwise
be deemed to have expressly or impliedly waived any of its rights, powers and/or remedies unless such waiver shall be in writing
and signed by an authorized officer of HCM. Any such waiver shall be enforceable only to the extent specifically set forth therein.
A waiver by HCM of any right, power and/or remedy on any one occasion shall not be construed as a bar to or waiver of any such
right, power and/or remedy which HCM would otherwise have on any future occasion, whether similar in kind or otherwise.

 

45.           Waiver of Counterclaims. PFO waives all rights to interpose any claims, deductions, setoffs or counterclaims
of any nature (other than compulsory counterclaims) in any action or proceeding with respect to this Agreement, the Claim(s), the
Recovery, HCI Return or any matter arising therefrom or relating hereto or thereto.

 

    	 	24	 

     

    

 

46.           Indemnification. PFO shall, jointly and severally, indemnify and hold HCM, HCI, and their directors, agents,
employees and counsel, harmless from and against any and all losses, claims, damages, liabilities, costs or expenses imposed on,
incurred by or asserted against any of them in connection with any litigation, investigation, claim or proceeding commenced or
threatened related to the negotiation, preparation, execution, delivery, enforcement, performance or administration of this Agreement,
or any undertaking or proceeding related to any of the transactions contemplated hereby or any act, omission, event or transaction
related or attendant thereto, including amounts paid in settlement, court costs, and the fees and expenses of counsel. To the extent
that the undertaking to indemnify, pay and hold harmless may be unenforceable because it violates any law or public policy, PFO
and shall, jointly and severally, pay the maximum portion which it is permitted to pay under applicable law to HCM or HCI in satisfaction
of indemnified matters. The foregoing indemnity shall survive the payment of HCI Return and the termination or non-renewal of this
Agreement.

 

47.           Termination. This Agreement is to become effective as of the effective date first mentioned above after it
has been signed by all Parties and acknowledged by the Attorney of Record. This Agreement and any Assignment automatically terminates
after PFO pays to HCI all amounts due to HCI, pursuant to the terms of this Agreement, for its HCI Return.

 

48.           Term. No termination of this Agreement shall relieve or discharge PFO of its respective duties, obligations
and covenants under this Agreement until HCI Return has been fully and finally discharged and paid, and HCI’s continuing
security interest in the Recovery, the Claim(s) and/or HCI Return and the rights and remedies of HCM and HCI hereunder, under applicable
law, shall remain in effect until all such HCI Return has been fully and finally discharged and paid.

 

49.           Corporate Resolution and Approval. PFO hereby confirms that this Agreement was approved and authorized by
the board of directors of the Corporation in accordance with Schedule “C;”

 

50.           Approval by Shareholders. PFO hereby confirms that this Agreement was approved and authorized by the sole
shareholder of the Corporation in accordance with Schedule “D.”

 

    	 	25	 

     

    

 

51.           Notices. All notices, requests and demands hereunder shall be in writing and deemed to have been given or
made: if delivered in person, immediately upon delivery; if by email, telex, telegram or facsimile transmission, immediately upon
sending and upon confirmation of receipt; if by nationally recognized overnight courier service with instructions to deliver the
next business day, one (1) business day after sending; and if by certified mail, return receipt requested, five (5) business days
after mailing. All notices, requests and demands upon the Parties are to be given to the following addresses (or to such other
address as any party may designate by notice in accordance with this Section 51.

 

If to PFO:

 

		PFO Global, Inc.
	 	7501 Esters Blvd., Suite 100
	 	Irving, TX 75063

 

If to HCM (and if to HCI, in care of HCM at):

 

			Hillair Capital Management LLC

345 Lorton Avenue, Suite 303

			Burlingame, CA 94016

			Attention: Sean M. McAvoy

			email: seanm@hillaircapital.com

			

 

With a copy (which shall not
constitute notice) to:

 

			Thompson Hine LLP

			3900 Key Center

			127 Public Square

			Cleveland, OH 44114

			Attn: David D. Watson

			email: david.watson@thompsonhine.com

			facsimile: 216.566.5800

 

52.           Partial Invalidity. If any provision of this Agreement is held to be invalid or unenforceable, such invalidity
or unenforceability shall not invalidate this Agreement as a whole, but this Agreement shall be construed as though it did not
contain the particular provision held to be invalid or unenforceable and the rights and obligations of the Parties shall be construed
and enforced only to such extent as shall be permitted by applicable law.

 

    	 	26	 

     

    

 

53.           Successors. This Agreement, any other agreements between the Parties and any other document referred to herein
or therein shall be binding upon and inure to the benefit of and be enforceable by HCM and HCI, as the case may be, PFO and its
respective successors and assigns, except that PFO may not assign its rights under this Agreement and any other document referred
to herein or therein without the prior written consent of HCM. HCM may, after notice to PFO, assign its rights and delegate its
obligations under this Agreement and further on behalf of HCI may assign, or sell participations in, all or any part of the Investment
or HCI Return or any other interest herein to another financial institution or other person, in which event, the assignee or participant
shall have, to the extent of such assignment or participation, the same rights and benefits as it would have if it were HCM or
HCI hereunder, except as otherwise provided by the terms of such assignment or participation.

 

54.           HCI and HCM.

 

HCI is an intended third party of all of the
rights and remedies provided to it hereunder, able to exercise such rights and remedies as if a party hereto. HCI has no duties
or obligations whatsoever to PFO under this Agreement or otherwise. HCM has the right, power and authority to act on behalf of
HCI to exercise any and all of its rights and remedies hereunder. PFO is entitled to rely on any act of HCM as binding on HCI.

 

55.           Entire Agreement. This Agreement, any supplements hereto, and any instruments or documents delivered or to
be delivered in connection herewith or therewith represents the entire agreement and understanding concerning the subject matter
hereof and thereof between the Parties hereto, and supersede all other prior agreements, understandings, negotiations and discussions,
representations, warranties, commitments, proposals, offers and contracts concerning the subject matter hereof, whether oral or
written. In the event of any inconsistency between the terms of this Agreement and any schedule or exhibit hereto, the terms of
this Agreement shall govern.

 

    	 	27	 

     

    

 

56.           Counterparts, Headings, Etc. This Agreement or any of the other agreements between the Parties may be executed
in any number of counterparts, each of which shall be an original, but all of which taken together shall constitute one and the
same agreement. Delivery of an executed counterpart of this Agreement by telefacsimile shall have the same force and effect as
the delivery of an original executed counterpart of this Agreement. Any party delivering an executed counterpart of any such agreement
by telefacsimile shall also deliver an original executed counterpart, but the failure to do so shall not affect the validity, enforceability
or binding effect of such agreement. The headings in this Agreement are for convenience or
reference only and shall not govern the interpretation of the provisions of the Agreement.

 

57.           No Legal Capacity. PFO acknowledges that by entering into this Agreement,
HCM is not acting in a legal capacity, and nothing contained herein shall constitute legal advice from HCM.

 

IN WITNESS WHEREOF, PFO and HCM hereby
execute this Agreement as of the effective date first written above.

 

PRO FIT OPTIX, INC.

 

 

/s/ Brigitte Rousseau                                

By:    Brigitte Rousseau

Title: Chief Financial Officer

 

 

	State of Texas	)
	 	)SS:
	County of Denton	)

 

 

On this 4th day of March 2016 before me
a notary public, the undersigned officer, personally appeared [name], known to me (or satisfactorily proven) to be the person
whose name is subscribed to the within instrument, and acknowledged that he executed the same for the purposes therein contained.

 

In witness hereof, I hereunto set my hand and official seal.

 

 

Regi J. Thomas                                           

Notary Public

 

HILLAIR CAPITAL MANAGEMENT LLC

 

 

/s/ Sean M. McAvoy                                

Sean M. McAvoy, Managing Member

 

    	 	28	 

     

    

 

SCHEDULE “A”

attached and made a part of that certain

CLAIM INVESTMENT AGREEMENT

 

		(a)	Recovery shall mean and include all of PFO’s right, title and interest in and to all settlements, judgments and awards
from any court, agency or other government authority, or from any arbitrator, and all other gross amounts, that shall at any time
be granted to, recovered by or paid to PFO as the direct or indirect result of the pending Claim(s) (including any appeals taken
therefrom or any settlement thereof) which PFO filed against the Defendants and any other defendants that may be added or substituted;
and

 

		(b)	Recovery shall also include any and all direct or indirect options and rights arising from or otherwise relating to, any additions,
extensions, renewals, refinancings, and/or other modifications, replacements of, increases in, profits, interest, dividends, stocks,
bonds, repurchase agreements, certificates of deposit, any other financial instruments, distributions and other income and payments
on account of proceeds of any replacement, release, surrender, discharge, exchange, conversion, arrangement or other transfer,
in kind payment, collection or sale, lease or other disposition of any of the things referred to in clause (a) above, whether arising
from any action taken by PFO or otherwise; and

 

		(c)	Recovery shall also include all proceeds and products of any of the things referred to in clauses (a) and (b) above;

 

		(d)	In the event any recovery is received using in-kind payment, PFO and HCM agree that HCM shall be the valuation agent for purposes
of this Agreement.

 

 

 

    	 	29	 

     

    

 

“SCHEDULE “B”

attached to and made a part of that certain

CLAIM INVESTMENT AGREEMENT

 

“ASSIGNMENT OF CASH RECOVERY”

 

Pro fit Optix, Inc (“PFO”) hereby makes this Assignment
of Recovery (this “Assignment”) on the following terms:

 

		1.	Capitalized terms used in the Assignment and not defined in context shall have the respective meanings give to such terms in
that certain Claim Investment Agreement (the “Claim Investment Agreement”) dated _______________, ___.2016 between
PFO and Hillair Capital Management LLC (“HCM”).

 

		2.	PFO hereby assigns, transfers and sets over to Hillair Capital Investment L.P. (“HCI”) its right, title and interest
in and to any Recovery actually received by PFO from the Claim(s) filed by PFO and more fully described in Schedule “A”
attached hereto and made a part hereof, as continuing and collateral security for the payment of obligation due and owing by PFO
to HCI, its successors, heirs or assigns, pursuant to that certain Claim Investment Agreement (the “Claim Investment Agreement”).
PFO hereby acknowledges that this Assignment is intended to, and shall vest in HCI a present right to any Recovery to the extent
that the obligation is actually due and owing to HCI pursuant to the Claim Investment Agreement.

 

		3.	PFO hereby authorizes and instructs Walsh Law Firm, or any of their successors and assigns, and any attorney subsequently engaged
by PFO with respect to the Claim(s), whether in addition to or in substitution for any of the aforementioned lawyers, or their
successors, heirs and assigns, to recognize HCI’s rights herein set forth, whether or not notice thereof was given by HCI
to attorney, and pay to HCI from and out of any Recovery, any amount due and owing from PFO to HCI pursuant to the Claim Investment
Agreement. PFO hereby acknowledges and agrees that HCI (or HCM acting on HCI’s behalf) shall be authorized to file an executed
copy of this Assignment of Recovery with any attorney for the purpose of providing notice of the existence of this Assignment and
its rights hereunder.

 

    	 	30	 

     

    

 

		4.	Upon payment to HCI of its share of the Recovery in full satisfaction of PFO’s obligations under the Claim Investment
Agreement, this Assignment will become void and of no further effect. This Assignment shall be binding upon PFO and its successors
and assignees, and shall inure to the benefit of, and be enforceable by, HCI and its successors and assignees.

 

		5.	This Assignment shall be governed by and construed, interpreted and enforced in accordance with the internal laws of the State
of California, without regard to the principles of conflict of laws.

 

[signatures
appear on the following page]

 

 

    	 	31	 

     

    

 

IN WITNESS WHEREOF, PFO and HCM hereby
execute this Assignment as of the dates set forth below:

 

PRO FIT OPTIX, INC.

 

/s/ Brigitte Rousseau                                   

By:     Brigitte Rousseau

Title:  Chief Financial Officer

 

 

	State of Texas	)
	 	)SS:
	County of Denton	)

 

 

On this 4th day of March 2016 before me a notary
public, the undersigned officer, personally appeared Brigitte Roussean, known to me (or satisfactorily proven) to be the person
whose name is subscribed to the within instrument, and acknowledged that he executed the same for the purposes therein contained.

 

In witness hereof, I hereunto set my hand and official seal.

 

Regi J. Thomas                                            

Notary Public

 

 

 

 

 

 

HILLAIR CAPITAL MANAGEMENT LLC

 

/s/ Sean M. McAvoy                                

Sean M. McAvoy, Managing Member

 

    	 	32	 

     

    

 

SCHEDULE “C”

attached to and made a part of that certain

CLAIM INVESTMENT AGREEMENT

 

 

“CERTIFICATE
OF CORPORATE RESOLUTION APPROVING AND

AUTHORIZING THE UNDERLYING CLAIM INVESTMENT
AGREEMENT”

 

I, Brigitte Rousseau,  Chief Financial Officer of the
Corporation, organized and existing under the laws of Wyoming and having its principal place of business at 7501 Esters
Blvd., Suite 100, Irving, TX 75063, hereby certify that the following is a true copy of a resolution adopted by the
board of directors of the Corporation on March 4, 2016, and that such resolution is now in full force and effect
and is in accordance with the provisions of the charter and by-laws of the Corporation.

 

			RESOLVED: That the Claim Investment Agreement in the form presented to the Board of Directors be, and hereby is, approved;
that the President of the Corporation be, and hereby is, authorized and directed in the name and on the behalf of the Corporation
to executed and deliver the Claim Investment Agreement; and that the officers of the Corporation be, and hereby are, authorized
and direct to do, and to cause to be done, all things necessary or desirable to cause the Corporation to fully and timely perform
its obligations under the Claim Investment Agreement.

 

			RESOLVED: That the Corporation is hereby authorized to accept the funding from Hillair Capital Investment L.P. in accordance
with the Claim Investment Agreement.

 

I further certify that this Corporation is duly organized and
existing, and has the power to take the action called for by the foregoing resolution.

 

	/s/ Brigitte Rousseau	 	March 4, 2016
	Name: Brigitte Rousseau

                                                          Title:   Chief Financial Officer  
	 	Date

 

 

 

    	 	33	 

     

    

 

 

THE REMAINDER OF THIS PAGE IS INTENTIONALLY
LEFT BLANK

SCHEDULE “D”

attached to and made a part of that certain

CLAIM INVESTMENT AGREEMENT

 

“SHAREHOLDER AFFIDAVIT”

 

The undersigned Brigitte Rousseau, being duly sworn deposes
and says:

 

That I am the Chief Financial
Officer of PFO Global, Inc, a Wyoming corporation (the “Company”), having their principal place of business at
7501 Esters Blvd., Suite 100, Irving, TX 75063

 

That the Company is the record and beneficial owner of 100%
of the outstanding shares of stock of Pro Fit Optix, Inc. (“PFO”)

 

That the Company has taken all necessary corporate action to
approve the execution, delivery and performance of the Claim Investment Agreement, dated as of even date herewith, between PFO
and Hillair Capital Management LLC.

 

IN WITNESS WHEREOF I have executed
this affidavit this 4th day of March, 2016

 

Brigitte Rousseau                                  

Brigitte Rousseau

 

 

	State of Texas	)
	 	)SS:
	County of Denton	)

 

 

Sworn to before me

this 4th day of March 2016

 

 

    	 	34	 

     

    

 

 

Regi J. Thomas                                     

Notary Public

 

 

 

THE REMAINDER OF THIS PAGE IS INTENTIONALLY
LEFT BLANK

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	35	 

     

    

  

SCHEDULE “E”

attached to and made a part of that certain

CLAIM INVESTMENT AGREEMENT

 

“ATTORNEY ACKNOWLEDGMENT AND UNDERTAKING”

 

Jim Walsh, of Walsh Law Firm, an attorney duly licensed
to practice law in the state of California, hereby issues this Attorney Acknowledgment and Undertaking as the Attorney of Record
with respect to the Claim(s), as set forth in this Agreement:

 

		1.	I acknowledge notice of the provisions of the foregoing Agreement, including without limitation the assignment and lien set
forth therein, and agree to disburse in compliance therewith the Recovery, if any, recovered on behalf of Pro fit Optix, Inc. (“PFO”)
with respect to the Claim(s).

 

		2.	I acknowledge, confirm and represent to HCM that I am the custodian of HCI’s funds upon obtaining a recovery on behalf
of PFO with respect to the Claim(s), and shall owe a fiduciary duty to HCI. We shall not distribute any funds or make any payments
to PFO prior to satisfying HCI’s lien in full.

 

		3.	I acknowledge, confirm and represent to HCI that I shall take no steps to circumvent the rights and obligations set forth in
this Agreement in any way whatsoever.

 

		4.	I acknowledge that the power of attorney issued by PFO in favor of HCI pursuant to Section 28 hereof is a duly authorized and
valid instrument.

 

		5.	I acknowledge and agree to be bound by the terms of Sections 6, 36, 41, and 42 of the underlying Claim Investment Agreement.
Furthermore, any dispute, claim or controversy arising out of or relating in any way to this Agreement, including this Attorney
Acknowledgement and Undertaking, or the breach, termination, enforcement, interpretation or validity thereof, including any determination
regarding the scope or applicability of this agreement to arbitrate, shall be determined by mandatory, final and binding arbitration

 

    	 	36	 

     

    

 

		6.	I acknowledge and confirm to HCM and HCI that HCI is under no obligation to reduce its lien or HCI Return in the event a recovery
is obtained on behalf of PFO.

 

		7.	In the event of any dispute between PFO and HCM or HCI regarding PFO’s obligations to HCI and/or the amount due to HCI,
I hereby acknowledge PFO’s irrevocable instructions and agree to deposit into our client trust account the full amount of
the proceeds from the Claim(s) paid to PFO by or on behalf of one or more of the Defendants. Said amount shall remain in our client
trust account until resolution of such dispute.

 

		8.	I agree not to interplead any part of the Recovery unless such interpleader is expressly initiated or requested in writing
by HCM.

 

		9.	I agree to deposit any Investment paid by HCI into my client trust account and use such Investment only for paying the cost
and expenses associated with prosecuting the Claim.

 

		10.	I agree to conspicuously mark PFO’s file to reflect the existence of HCI’s lien.

 

		11.	I represent to HCM and HCI , as defined in this Agreement, that I have not been given any notice of liens, assignments, transfers
or conveyances of any portion of the Recovery from the Claim(s) except as set forth herein.

 

		12.	In the event I am terminated as PFO’s Attorney of Record with respect to the Claim, I shall give HCM immediate written
notice thereof both by certified mail, return receipt requested, and via email, and state the name, address and telephone number
of PFO’s new attorney. Pursuant to Section 34 of the underlying Claim Investment Agreement, at HCM’s request, I hereby
agree to keep HCM updated regarding any changes affecting this case and to provide detailed written monthly updates regarding the
case status, including any new contact information for PFO.

 

		13.	To the best of my information, knowledge and belief, (i) the provisions of the underlying Claim Investment Agreement do not
violate any law, regulation, order, judgment or decree of any governmental authority, (ii) no action, suit, investigation, litigation
or proceeding shall be pending or threatened in any court or before any arbitrator or governmental authority, which purports to
enjoin, prohibit, restrain or otherwise affect the making of the Investment, (iii) such Investment is not against public policy.

 

    	 	37	 

     

    

 

		14.	I hereby inform HCM that liability is contested in this case, there are no assurances that PFO will prevail, and there is substantial
uncertainty as to the amount, if any, PFO may recover.

 

 

 

Please list all known liens below. If none, so state. This
section must be completed by PFO’s Attorney of Record only.

 

	NAME		AMOUNT	 	DATE
	 	 	 	 	 
		 	 	 	 
	 	 	 	 	 
		 	 	 	 

 

 

 

 

/s/ Jim Walsh                                           

Jim Walsh

 

    	 	38Exhibit 10.2

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

This Executive Employment Agreement (“Agreement”)
is between PFO Global, Inc. (“Company”) and Matt Cevasco (“Executive”) and
is effective as of February 29, 2016 (“Effective Date”). In consideration of the mutual covenants set
forth herein, Company and Executive (collectively “the Parties” and each individually a “Party”)
agree as follows:

 

1.          Executive’s Employment with Company. During the Term, Company agrees to employ Executive as Chief Executive
Officer of Company or in any other position to which the Parties subsequently agree. During Executive’s employment with Company,
Executive agrees to devote all of Executive’s time, energy, skill and best efforts to the performance of Executive’s
job duties, as assigned by Company, and to the business of Company, and shall perform such duties as assigned by Company –
which duties may change from time to time – in a diligent, trustworthy, and business-like manner and in compliance with all
applicable laws. While frequent travel may be required of Executive in Executive’s performance of Executive’s job duties
for Company, Executive’s primary work location shall be located in Irving, Texas or any other location at which Company’s
headquarters may be located during the Term. Executive shall not at any time during Executive’s employment with Company:
(a) work on any basis (including, without limitation, part-time or as an independent contractor) for a Competing Business (as defined
in Section 5(d)); or (b) participate in any way in any other business that is not a Competing Business to the extent that
such participation adversely affects Executive’s performance of Executive’s job duties for Company or may or does adversely
affect Company in any way. Executive acknowledges and agrees that Executive will comply with Company’s existing and future
policies, manuals and procedures as adopted and provided to Executive.

 

2.          Term of Agreement. Executive’s employment with Company pursuant to the terms of this Agreement will
begin on the Effective Date and will remain in effect for a one (1) year period immediately after the Effective Date, unless earlier
terminated in accordance with Section 7 (“Initial Term”), and, unless either Party sends the other
Party a notice of intent not to renew at least sixty (60) days prior to the expiration date of the applicable term, shall renew
for one or more additional one (1) year term(s), subject to earlier termination pursuant to Section 7 (each, a “Renewal
Term”) thereafter. (The Initial Term and any Renewal Term is referred to herein collectively as the “Term.”)

 

3.          Compensation and Benefits.

 

(a)         Company shall pay Executive an annual
base salary of $225,000.00 paid in equal lesser amounts on a twice monthly basis in accordance with Company’s normal payroll
practices, subject to all required and/or authorized withholdings and deductions, (“Base Salary”) for
all services rendered by Executive to Company or any of Company’s subsidiaries or affiliates.

 

(b)         Executive shall be eligible to participate
in a discretionary annual bonus plan, through which plan Executive may receive an annual bonus of up to forty percent (40%) of
the Base Salary (“Discretionary Bonus”), pursuant to the terms and conditions of such discretionary annual
bonus plan (“Bonus Plan”). The Parties shall determine the performance metrics which must be met, if
any, for any such Discretionary Bonus to be paid to Executive under the Bonus Plan, with such performance metrics containing short-term,
mid-term and long-term goals in accordance with the following categories:

 

	Percent of any Discretionary Bonus	Performance Metrics
	10%	Sales objectives to be set exceeded
	10%	Financial objectives to be set met
	5%	Strategic plan objectives set by Company’s Board of Directors (“Board”) met
	5%	Company employee retention and pay objectives set by Board met
	5%	Effective  communication with Company employees, customers, Board and other Company contacts as determined by Board
	5%	Effective Company training and  personnel management  as determined by Board

  

    

PAGE 1 OF 8

     

    

 

Any Discretionary Bonus payable to Executive
for a relevant calendar year will be paid on or before March 15 of the immediately following calendar year, provided that, Executive
is employed by Company on such payment date(s), with the portions of any Discretionary Bonus concerning sales and financial objectives
being paid on a quarterly basis during the relevant calendar year subject to the terms and conditions of the Bonus Plan and Company
budget.

 

(c)          Executive shall receive the option
to purchase up to five percent (5%) of the Class A Common Stock of Company for the amount of $0.30 per share subject to the terms
and conditions of the PFO Global, Inc. 2015 Equity Incentive Plan, as existing and as may be amended from time to time, and subject
to vesting requirements over a five-year period, the requirement that Executive sign a Subscription Agreement to receive such option
to purchase the Class A Common Stock, and the terms and conditions of the Subscription Agreement.

 

(d)          Executive shall be eligible to participate
in any Executive benefit plans maintained by Company subject to the terms and conditions of such plans as they may be amended from
time to time.

 

(e)          Company shall provide Executive
$800.00 per month during the Term for Executive’s use in purchasing or leasing an automobile for the Executive’s use
in the Executive’s performance of Executive’s job duties for Company. Additionally, Executive’s use of, and responsibilities
concerning, such automobile are subject to any Company automobile use policies as they may exist from time to time.

 

(f)          Subject to Section 16, Company
will reimburse Executive for reasonable and necessary travel and other business expenses Executive incurs that are directly related
to the Executive’s performance of Executive’s job duties for Company. Such expenses shall be reimbursed after Executive
presents Company with documentation acceptable to Company of such expenses and in accordance with Company’s travel and business
expense reimbursement policies as they may exist and be amended from time to time.

 

(g)          Subject to Section 16, during
the Initial Term, Company will reimburse Executive up to $1,000.00 per month for amounts spent by Executive renting temporary living
accommodations during the Initial Term and up to $1,500.00 per month for flights during the Initial Term between the city of Executive’s
primary residence as of the Effective Date and the Dallas/Fort Worth Metroplex. Such expenses shall be reimbursed after Executive
presents Company with documentation acceptable to Company of such expenses and in accordance with Company’s travel and business
expense reimbursement policies as they may exist and be amended from time to time.

 

(h)          Compensation shall only be required,
and Executive’s entitlement to any of the benefits referenced in this Section 3 shall only be in effect, during the
Term and any termination of Executive’s employment or of this Agreement shall terminate Company’s obligation to compensate
the Executive in any manner or provide any of the benefits referenced in this Section 3 for any period following the date
of Executive’s termination of employment or of this Agreement, unless otherwise required by applicable law, any applicable
plan documents as they may be amended from time to time, or Section 8. All payments referenced in this Section 3
are subject to all required and/or authorized withholdings and deductions.

 

4.          Confidential
Information and Executive’s Non-Disclosure Agreement. During Executive’s employment with Company, Company agrees
to provide Executive with Confidential Information (defined below) to which Executive has not previously had access. For purposes
of this Agreement “Confidential Information” includes trade secrets or confidential information of Company,
including, without limitation: client, referral source, business partner, investor and/or vendor identity, lists, databases, contact
information, preferences, upcoming needs, and/or other information and/or history; contracts; processes; technical data; policies;
pricing, costs, marketing, sales, business, marketing and/or other strategies, studies, analysis, plans or practices; designs;
testing results; business and/or training manuals; business and/or financial information; audit processes; management methods and/or
information; any original works of authorship by Company; or other business information disclosed to the Executive by Company,
either directly or indirectly, in writing, orally, or by drawings or observation and whether disclosed to Executive before or after
the Effective Date. Executive understands and agrees that Company is not required to provide Executive with all of the types of
Confidential Information listed in the preceding sentence, but that Company will provide the Executive with access to some of these
types of Confidential Information to which Executive did not have access prior to the Effective Date in a manner and at a time
in Company’s sole discretion. In exchange for Company’s promise to

    

PAGE 2 OF 8

     

    

 

provide Executive with Confidential Information,
Executive shall not, during the period of Executive’s employment with Company or at any time thereafter, take, disclose,
publish, use, exploit, or solicit, allow or assist another person to use, take, disclose, publish or exploit any Confidential Information,
except as: (a) required in the ordinary course of Company’s business directly related to the Executive’s employment
with Company and for the benefit of Company; or (b) required by law. Executive represents that Executive’s performance
of all the terms of this Agreement and Executive’s job duties for Company do not, and will not, breach any agreement with
any third party, and Executive will not, and acknowledges that Company has specifically instructed Executive not to, disclose to
Company, use, or induce Company to use any confidential or proprietary information or material belonging to any previous employer
or other third party. Additionally, during Executive’s employment, Company or Executive in performing Executive’s job
duties for Company may receive from third parties their confidential information. Executive agrees not to take, use, publish, exploit
or disclose it to any person or organization except as necessary in the course of Executive’s employment with Company and
in accordance with any use agreement between Company and such third party. Furthermore, upon request by Company or upon the termination
of Executive’s employment with Company for any reason, Executive shall immediately return and deliver to Company any and
all Confidential Information and all other Company documents and items – whether in hard or digital form – and all
copies thereof which belong to Company or any of Company’s subsidiaries or affiliates or relate to the business of Company
or any Company subsidiary or affiliate and which are in Executive’s possession, custody or control, whether prepared by Executive
or others. Executive further agrees that, after Executive provides a copy of such information or documents to Company, Executive
will immediately delete and write over any information or documents relating to the business of Company or any of Company’s
subsidiaries or affiliates from any computer, cellular phone or other digital or electronic device owned by Executive and, upon
request by Company, provide such computer, cellular phone or other digital or electronic device to Company or Company’s designee
for inspection to confirm that such information and documents have been deleted and written over so the information and documents
cannot be retrieved.

 

5.          Executive’s Non-Competition,
Non-Solicitation, and Non-Recruitment Covenants. Executive recognizes and agrees that: (i) prior to Executive’s employment
with Company, Executive had no business or other relationships with any prior, current or prospective clients or vendors of Company;
(ii) Company has devoted a considerable amount of time, effort, and expense to develop its Confidential Information and business
goodwill; (iii) the Confidential Information and Company’s business goodwill are valuable assets to Company and give Company
a competitive advantage over others who do not have this information; and (iv) any unauthorized use or disclosure of Company’s
Confidential Information and/or damage to Company’s business goodwill would cause irreparable harm to Company for which there
is no adequate remedy at law. For these reasons, Executive agrees that to protect Company’s Confidential Information and
business goodwill, it is necessary to enter into the following restrictive covenants. During the Non-Competition Period (defined
below), Executive, individually or as a principal, director, officer, partner, manager, contractor, Executive, lender, investor,
volunteer or in any other manner or capacity whatsoever, shall not, directly or indirectly:

 

(a)          Become employed
by, invest in, finance, advise, endorse, perform services for, or otherwise engage in any capacity with a Competing Business in
the Restricted Area; provided that the ownership by Executive of any stock listed on any national securities exchange of any corporation
conducting a Competing Business shall not be deemed a violation of this Agreement if the aggregate amount of such stock owned by
Executive does not exceed two percent (2%) of the total outstanding stock of such corporation. Executive shall be deemed
to be engaging in business in the Restricted Area if Executive on behalf or for the benefit of any Competing Business uses any
electronic or digital device that is physically located in the Restricted Area to communicate with any person, whether or not such
other person is physically located in the Restricted Area, or on behalf or for the benefit of any Competing Business, Executive
uses any telecommunication device located outside the Restricted Area to communicate with any person located in the Restricted
Area;

 

(b)          Solicit business
from, attempt to transact business with, or transact business with, except on behalf of Company during Executive’s employment
with Company, any current or prospective client, investor or business partner of Company which: (i) Executive contacted, called
on, serviced, did business with or had contact with during Executive’s employment with Company; or (ii) Executive learned
of or obtained Company’s Confidential Information about during Executive’s employment with Company. This restriction
applies only to soliciting, attempting to transact business, or transacting business for a Competing Business. Additionally, Executive
agrees that, among other actions, any notification, update or other communication to any such current or prospective client, investor
or business partner of Executive’s non-employment with Company or Executive’s relationship or status with any Competing
Business – whether such notification or update is through LinkedIn, Facebook, any other social media outlet, email, letter
or by any other method – constitutes a solicitation of business and an attempt to transact business with such current or
prospective client, investor or business partner; and/or

 

    

PAGE 3 OF 8

     

    

 

(c)          Hire, solicit
for employment, contract with, or induce or encourage to leave the employment or contracting relationship with Company, on behalf
of Executive or any other person or entity, any employee or independent contractor of Company or any former contractor or employee
of Company, unless such former contractor or former employee’s relationship with Company has been terminated for at least
twelve (12) months as of the time of such hiring, solicitation, contracting, inducement or encouragement.

 

(d)          “Non-Competition Period”
means during the Executive’s employment with Company and for a period of one year after the Executive’s employment
with Company ceases for whatever reason. “Competing Business” or “Business”
means any individual, entity or business that provides the same or similar services and products as Company, which includes, without
limitation, the development, manufacture, marketing and/or selling of lenses and/or eyewear; any goods or services that are the
same or substantially the same as the goods and/or services provided by Company; and any other line of business in which Company
becomes involved or takes steps to become involved during Executive’s employment with Company, provided that Executive has
knowledge of Company becoming involved in such other line of business or any of the steps taken by Company to become involved in
such other line of business. As Company’s products are sold at retail locations throughout the United States of America and
internationally, “Restricted Area” for purposes of this Agreement is: (i) any county, parish or similar
political subdivision: (A) in which the Executive performed any services for Company during Executive’s employment with Company;
concerning which the Executive received Company’s Confidential Information regarding Company’s business during Executive’s
employment with Company (e.g. Company provided Executive with information about Company’s plan to expand into such geographic
area, Company provided Executive with confidential data about relevant market within the geographic area, etc.); (C) in which an
office of Company is located for which the Executive had supervisory or managerial responsibilities during Executive’s employment
with Company; or (D) in which any Company office or location is located that was the Executive’s primary office or an office
from which the Executive regularly worked during Executive’s employment with Company or for which the Executive provided
services; (ii) Texas; and (iii) the United States of America.

 

(e)          Executive acknowledges that the
restrictions contained in Sections 4 and 5, in view of the nature of Company’s business and Company’s Confidential
Information and business goodwill, are reasonable and necessary to protect Company’s legitimate business interests and goodwill.
Therefore, Executive agrees that Company shall be entitled to a temporary restraining order and injunctive relief, without the
posting of bond, restraining Executive from the commission of any breach of Sections 4 and/or 5 and to recover Company’s
attorneys’ fees, witness fees, costs and expenses related to any breach or threatened breach of this Agreement or any action
or proceeding brought relating to this Agreement. Nothing contained in this Agreement shall be construed as prohibiting Company
from pursuing any other remedies available to it for any breach or threatened breach, including, without limitation, the recovery
of money damages. The existence of any claim or cause of action by Executive against Company, whether predicated on this Agreement
or otherwise, shall not constitute a defense to the enforcement by Company of Sections 4 and/or 5 of this Agreement. If
Executive violates any of the restrictions contained in Section 5, the Non-Competition Period will be suspended and
will not run in favor of Executive until such time that Executive cures the violation to the satisfaction of Company. If Executive,
in the future, seeks or is offered employment, or any other position with a Competing Business, Executive agrees to inform the
Competing Business, before accepting employment or any other position, of the existence of the restrictions in Sections 4 and
5. Further, before taking any employment or other position with any Competing Business during the Non-Competition Period, Executive
agrees to give prior written notice to Company of the name of such Competing Business. Company shall be entitled to advise such
Competing Business of the provisions of Sections 4 and 5 and to otherwise deal with such Competing Business to ensure that
the provisions of Sections 4 and 5 are enforced and duly discharged.

 

    

PAGE 4 OF 8

     

    

 

6.          Ownership of Information, Inventions,
and Original Works. “Materials” means all ideas, inventions, works of authorship, concepts, processes,
formulas, data, computer programs, improvements, discoveries, developments, designs, and techniques related to the Business or
any current or planned line of business of Company that are authored, conceived, or reduced to practice by Executive, either alone
or jointly with others, during Executive’s employment with Company. “Intellectual Property Rights”
means patents, copyrights, trademarks, trade secrets, and moral rights. All Intellectual Property Rights in Materials shall be
and shall remain owned by Company and shall be Confidential Information. To the extent applicable, the Materials are to be considered
works made for hire, as that term is defined in the United States Copyright Act (17 U.S.C. § 101). Executive hereby irrevocably
assigns and shall be deemed to have assigned to Company all of Executive’s right, title and interest in and to any and all
Materials, including any related Intellectual Property Rights, whether or not patentable or registrable under copyright or similar
statutes. Executive recognizes that this Agreement does not require assignment of any Materials (i) developed entirely on the Executive’s
own time; and (ii) developed without equipment, supplies, facility, trade secrets, or proprietary information of Company. Executive
will promptly and fully disclose to Company any and all Materials at the time such Materials are first reduced to practice or first
fixed in a tangible form. Executive will, at Company’s expense, assist Company to obtain and enforce United States and foreign
Intellectual Property Rights relating to Materials. Executive will execute, verify and deliver documents and perform other acts
as Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Intellectual
Property Rights and the assignment thereof. All inventions and works of authorship, if any, patented or unpatented, registered
or unregistered, that the Executive made prior to the Effective Date that are not owned by Company are listed on an attachment
hereto (hereafter referred to as the “Prior Materials”). If no such list is attached, Executive represents
that the Executive does not own or possess any Prior Materials. Executive shall not use any Prior Materials in any manner in connection
with the Business. If Executive incorporates Prior Materials owned by Executive, or in which Executive has an interest, into any
Materials, Company is hereby granted and shall have a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide,
sublicensable (directly or indirectly) license to make, have made, modify, use, sell, have sold, copy, distribute, create derivative
works, display, perform, and transmit such Prior Materials.

 

7.          Termination of Employment.
The employment relationship between Executive and Company shall terminate and the Term shall terminate upon the occurrence of any
one of the following events:

 

(a)          Death or Disability. Executive’s
employment with Company shall be terminated effective immediately on the death or Disability of Executive. “Disability”
shall mean that Executive is, (i) by reason of any medically determinable physical or mental impairment, unable to perform the
essential functions of Executive’s job position with Company, with or without reasonable accommodation, for six (6) months
– whether such six (6) months be continuous or intermittent – within a twelve (12) month period, (ii) determined to
be disabled under the terms of any long-term disability plan in effect for Company employees at the applicable time, or (iii) determined
to be disabled by the U.S. Social Security Administration.

 

(b)          Termination for Cause. Company
may terminate Executive’s employment with Company for Cause, which termination shall be immediately effective upon written
notice to Executive of such termination. “Cause” means Company’s termination of Executive’s
employment upon the occurrence of any of the following events:

 

(i)Any act of fraud, misappropriation,
embezzlement or dishonesty by Executive regarding any aspect of Company’s business;

 

(ii)The breach by Executive
of this Agreement or any other agreement between Executive and Company, which breach, if curable, Executive fails to cure within
thirty (30) days after written notice thereof from Company. If such breach is not curable, Company need not provide Executive notice
of such breach and wait any cure period before termination of Executive’s employment;

 

(iii)Executive being charged
with any felony or any crime of moral turpitude and which charge could, in the sole and reasonable judgment of Company, have an
adverse effect on Company, Company’s reputation, and/or Executive’s ability to perform Executive’s job position
with Company;

 

    

PAGE 5 OF 8

     

    

 

(iv)The failure of Executive
to reasonably perform in all material respects Executive’s duties and responsibilities in Executive’s job position
with Company and the failure of Executive to cure such failure within thirty (30) days after written notice thereof from Company;

 

(v)The failure or refusal
of Executive to follow the reasonable lawful directives of Company, which, if curable, Executive fails or refuses to cure within
thirty (30) days after written demand to perform such directives is delivered to Executive; or

 

(vi)Any act by Executive
of gross negligence, intentional waste, disloyalty or unfaithfulness by Executive concerning Company or any breach by Executive
of Executive’s fiduciary duties to Company or of Sections 4 or 5 of this Agreement.

 

(c)          Termination by Executive for
any Reason. Executive may terminate Executive’s employment with Company during the Term for any reason upon provision
of sixty (60) days advance written notice to Company. If Executive provides the sixty (60) days advance written notice of termination
to Company, Company may elect for Executive to provide no further services to Company at any point during the sixty (60) day period
after the provision of the advance written notice of termination (“Notice Period”). If Company makes
this election, the date upon which Company makes this election Executive’s employment with Company shall be terminated effective
immediately.

 

(d)          Termination by Company Without
Cause. Company may terminate Executive’s employment with Company during the Term without Cause immediately upon written
notice to Executive of such termination.

 

(e)          Termination by Expiration.The
Executive’s employment with Company shall terminate immediately upon expiration of the Term, as provided in Section 2.

 

8.          Compensation Upon Termination.
Upon the termination of Executive’s employment during the Term:

 

(a)          Executive shall be entitled to Executive’s
Base Salary before the effective date of termination of Executive’s employment with Company (“Termination Date”),
prorated on the basis of the number of full days of service rendered by Executive during the salary payment period prior to the
Termination Date. Company shall pay Executive the prorated Base Salary in accordance with applicable law, but no later than the
next regular payday after the Termination Date;

 

(b)          Subject to the provisions of Section
16, Executive shall be entitled to any unreimbursed reasonable business expenses incurred by Executive prior to the Termination
Date in accordance with Company’s then in effect business expense reimbursement policy and any amounts to which Executive
is entitled to under Company’s benefit plans in accordance with the terms of such plans as they may exist from time to time,
which any request for reimbursement and supporting documentation Executive must submit to Company within fourteen (14) days of
the Termination Date and shall be paid to Executive within thirty (30) days of Company’s receipt of Executive’s request
for reimbursement and appropriate supporting documentation.

 

(c)          By Company for Cause, death or Disability,
by the Executive for any reason (including, without limitation, any actual or alleged constructive discharge), or because of expiration
of the Term, Executive shall only receive the amounts and/or benefits listed in Sections 8(a) and (b), and Company shall
not owe Executive any further compensation.

 

(d)          By Company for any reason other
than Cause, death or Disability, Executive shall receive: (i) the amounts and/or benefits listed in Sections 8(a) and (b);
and (ii) an amount equivalent to six (6) months of the Base Salary (“Severance Payments”). Company shall
pay the amounts and/or benefits listed in Sections 8(a) and (b) as specified in those Sections. Company shall pay
the Severance Payments to Executive in equal twice monthly payments in accordance with Company’s normal payroll practices,
subject to all required and/or authorized withholdings and deductions, with the first payment being made to Executive on the first
regular payroll date of the first month following the sixtieth (60th) day after the Termination Date and the remaining
payments being made on Company’s regular payroll dates thereafter through the end of the six-month period immediately following
the Termination Date, provided that the first payment shall include any amounts that would otherwise have been payable during the
period between the Termination Date and the date of the first payment. Company’s obligation to make the Severance Payments
to Executive is contingent upon Executive signing and not revoking a separation and release agreement in a form acceptable to Company
and providing such signed separation and release agreement to Company no later than fifty (50) days after the Termination Date.
For the avoidance of doubt, any expiration of the Term shall not be a termination by Company that would require any payments to
Executive under this Section 8(d).

 

    

PAGE 6 OF 8

     

    

 

9.          Non-Disparagement.
Executive agrees that Company’s goodwill and reputation are assets of great value to Company which were obtained through
great cost, time and effort. Therefore, Executive agrees that during Executive’s employment with Company and after the termination
of Executive’s employment for any reason, Executive will not in any way disparage, libel or defame Company, its business
or business practices, its products or services, or its current, past or future employees, officers, directors or owners or interfere
in any way with Company’s operations or any of Company’s relationships with Company’s employees, business partners,
investors, vendors and/or independent contractors. This Section 9 does not prohibit Executive from providing truthful testimony,
providing truthful information as legally required to do so, or participating in any governmental proceeding.

 

10.          No Expectation of Privacy.Executive
understands and agrees that Executive has no expectation of privacy with respect to Company’s telecommunications, networking,
or information processing systems (including, without limitation, any stored, created or accessed computer files, information or
communications, e-mail messages, text messages, and voice messages) and that Executive’s activity and any files, information,
or communications on or use of any such systems may be accessed, monitored, copied, disclosed, used, and saved by Company at any
time without notice to Executive.

 

11.          Entire Agreement.
This Agreement is the entire agreement between the Parties with respect to the subject matter hereof, and supersedes any previous
agreements, written or oral, between Executive and Company with regard to the subject matter of this Agreement. This Agreement
may not be modified or amended orally, and any amendment or modification must be in writing and be signed by Executive and an authorized
representative of Company. Executive represents and acknowledges that, in executing this Agreement, Executive did not rely, and
has not relied, on any representation(s) by Company or any of its officers, directors, employees or representatives, except as
expressly contained in this Agreement. Rather, Executive relied on Executive’s own judgment.

 

12.          Partial Invalidity and Reformation.
In the event any court of competent jurisdiction holds any provision of this Agreement to be invalid or unenforceable, such invalid
or unenforceable portion(s) shall be limited or excluded from this Agreement to the minimum extent required, and the remaining
provisions shall not be affected and shall remain in full force and effect. Executive further agrees that in the event any of the
covenants contained in Section 5 are held by any court to be effective in any particular area or jurisdiction only if said
covenant is modified to limit its duration or scope, then the court shall reform the covenant and the Parties shall consider such
covenant(s) and/or other provisions of Section 5 to be amended with respect to that particular jurisdiction so as to comply
with the order of any such court and, as to all other jurisdictions, the covenants contained in Section 5 shall remain in
full force and effect as originally written.

 

13.          Assignment of Rights.
This Agreement shall be binding upon and inure to the benefit of Executive, Company and any parents, subsidiaries, affiliated companies,
successors or assigns of Company. Executive’s obligations under this Agreement shall be binding upon Executive’s heirs,
executors and assigns.

 

14.          Survival and Nonwaiver.
The obligations under Sections 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15 and 16 of this Agreement shall continue in effect after
the termination of Executive’s employment, regardless of the reason(s) for termination. Company’s waiver of any provision
of the Agreement shall not constitute (a) a continuing waiver of that provision or (b) a waiver of any other provision of this
Agreement.

 

    

PAGE 7 OF 8

     

    

 

15.          Governing Law. This
Agreement and the performance hereof shall be construed and governed in accordance with the laws of the State of Texas, and the
Parties waive the application of conflicts of laws provisions or principles of any state or jurisdiction. Further, the prevailing
Party in any legal proceeding based upon this Agreement shall be entitled to reasonable attorney’s fees and court costs,
in addition to any other recoveries allowed by law. Concerning any dispute arising out of or relating to this Agreement, the Parties
hereby irrevocably submit to the exclusive jurisdiction of any federal or state court located within Dallas County, Texas or, if
a mandatory venue provision is applicable, to the jurisdiction of any other federal or state court within the State of Texas required
to hear such matter by any such applicable mandatory venue provision. The Parties hereby irrevocably waive, to the fullest extent
permitted by applicable law, any objection which they may now or hereafter have to the laying of venue of any such dispute brought
in such court or any defense of inconvenient forum for the maintenance of such dispute. Each of the Parties agrees that a judgment
in any such dispute may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

 

16.          Section 409A. This
Agreement is intended to be interpreted and applied so that the payments and benefits set forth herein shall either be exempt from
the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, (“Section 409A”) or
shall comply with the requirements of Section 409A. In no event may Executive, directly or indirectly, designate the calendar year
of any payment to be made under this Agreement or otherwise which constitutes a “deferral of compensation” within the
meaning of Section 409A. Notwithstanding anything in this Agreement or elsewhere to the contrary, a termination of employment shall
not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits
that constitute “non-qualified deferred compensation” within the meaning of Section 409A upon or following a termination
of Executive’s employment unless such termination is also a “separation from service” within the meaning of Section
409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of
employment” or like terms shall mean “separation from service” within the meaning of Section 409A. With respect
to any expense, reimbursement or in-kind benefit provided pursuant to this Agreement that constitutes a “deferral of compensation”
within the meaning of Section 409A, (i) the expenses eligible for reimbursement or in-kind benefits provided to Executive must
be incurred during the Term, (ii) the amount of expenses eligible for reimbursement or in-kind benefits provided to Executive during
any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to Executive in
any other calendar year, (iii) the reimbursements for expenses for which Executive is entitled to be reimbursed shall be made on
or before the last day of the calendar year following the calendar year in which the applicable expense is incurred, and (iv) the
right to payment or reimbursement or in-kind benefits may not be liquidated or exchanged for any other benefit. Notwithstanding
any provision in this Agreement or elsewhere to the contrary, if on Executive’s termination of employment, Executive is deemed
to be a “specified employee” within the meaning of Section 409A, any payments or benefits due upon a termination of
Executive’s employment under any arrangement that constitutes a “deferral of compensation” within the meaning
of Section 409A (whether under this Agreement, any other plan, program, payroll practice or any equity grant) and which do not
otherwise qualify under the exemptions under Treasury Regulation section 1.409A-1 (including without limitation, the short-term
deferral exemption and the permitted payments under Treasury Regulation section 1.409A-1(b)(9)(iii)(A)), shall be delayed and paid
or provided to Executive in a lump sum (whether they would have otherwise been payable in a single sum or in installments in the
absence of such delay) on the earlier of (x) the date which is six months and one day after Executive’s separation from service
for any reason other than death, and (y) the date of Executive’s death, and any remaining payments and benefits shall be
paid or provided in accordance with the normal payment dates specified for such payment or benefit.

 

 

EXECUTIVE:PFO GLOBAL, INC.:

 

	EXECUTIVE:	 	PFO GLOBAL, INC.:	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	Signature: /s/ Matt Cevasco            	 	Signature:	/s/ Charles Posternak 	 	 
	Printed Name: Matt Cevasco           	 	Printed
    Name:	Charles Posternak 	 	 
	Date: February 29, 2016                    	 	Title:	Director	 	 

 

    
PAGE 8 OF 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]